Bosio Research Group

The directive of the Immunity to Pulmonary Pathogens Section (IPPS) is to further our understanding of how virulent pulmonary pathogens, including Francisella tularensis, Bordetella pertussis and SARS-CoV-2 evade and inhibit protective immunity in the lung. Our overall goal is to utilize this information for development of novel therapeutics and vaccines directed against a variety of infectious diseases. Additionally, through comparative studies using other pulmonary pathogens we aim to gain a comprehensive understanding of regulation of innate and adaptive immune responses in the lungs with a special emphasis on metabolism.

Photo of Bosio Research Group Members

From left to right: Tara Wehrly, Benji Schwarz, Lydia Roberts, Eric Bohrnsen, Monica Valtierra, Forrest Jessop, Katy Bosio

Credit: NIAID

Catharine (Katy) Bosio, Ph.D.

Chief, Immunity to Pulmonary Pathogens Section

Education:

Ph.D., 1998, Colorado State University

B.Sc., 1993, Washington State University

Dr. Bosio graduated from Washington State University cum laude with a B.Sc. in 1993, completed her Ph.D. at Colorado State University, and postdoctoral fellowships at the Food and Drug Administration Center for Biologics Evaluation and Research and at the U.S. Army Medical Research Institute for Infectious Diseases. She joined NIAID in 2007; her laboratory studies the host response to pulmonary pathogens.

Learn more about Catharine (Katy) Bosio, Ph.D.

Photo of Catharine (Katy) Bosio, Ph.D.

Forrest Jessop, Ph.D.

Biologist

Dr. Jessop primary interest is understanding how metabolic flux influences innate responses in the lung. Dr. Jessop utilizes a variety of infection models and both in vitro and in vivo models and techniques to characterize changes in metabolism after infection. Dr. Jessop’s goal is to use this information to design novel therapeutics for a wide variety of diseases.

Learn more about Forrest Jessop, Ph.D.

Portrait of Jessop Forrest, Ph.D.

Lydia M. Roberts, Ph.D.

Staff Scientist

Dr. Roberts primary interest in the development of T cell immunity in the lung. By using an array of comparative models Dr. Roberts is dissecting out the optimal metabolic milieu required to engender long lived T cell responses in the lung with the goal of development of improved vaccines.

Learn more about Lydia M. Roberts, Ph.D.

Portrait of Lydia Roberts, Ph.D.

Benji Schwarz, Ph.D.

Biochemist

Dr. Schwarz is the contact for the Immunometabolism Program housed within the IPPS.

Learn more about Benji Schwarz, Ph.D.

Portrait of Benji Schwarz, Ph.D.

Tara Wehrly

Biologist

Ms. Wehrly provides broad support across all projects in the laboratory. Ms. Wehrly also serves as lab manager for the IPPS.

Learn more about Tara Wehrly

Former Research Group Members

Rebecca V. Anderson, Ph.D.

Amanda Griffin, Ph.D.

Timothy Bauler, Ph.D.

Joshua B. Alinger, MD/Ph.D.

Elliot Wyatt, BSc

Katrina Diaz, MD/Ph.D.

Kaitlin Stromberg, BSc

Ian Leighton, BSc

Jennifer Chase, MSc

Deborah Crane, MSc

Robin Ireland, MSc

Content last reviewed on